Inhibition of lung tumor colonization and cell migration with the disintegrin crotatroxin 2 isolated from the venom of Crotalus atrox

Toxicon

Volumn 51, Issue 7, 2008, Pages 1186-1196

  Galán, Jacob A ^a   Sánchez, Elda E ^a   Rodríguez Acosta, Alexis ^b   Soto, Julio G ^c   Bashir, Sajid ^a   McLane, Mary Ann ^d   Paquette Straub, Carrie ^d   Pérez, John C ^a  

^a TEXAS A AND M UNIVERSITY KINGSVILLE   (United States)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c SAN JOSE STATE UNIVERSITY   (United States)

^d UNIVERSITY OF DELAWARE   (United States)

Author keywords

Cell migration; Crotalus atrox; Crotatroxin; Disintegrins; Lung tumor colonization; Venom

Indexed keywords

AMINO ACID; CROTATROXIN 2; DISINTEGRIN; SNAKE VENOM;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CANCER CELL; CELL ADHESION; CELL MIGRATION; CHROMATOGRAPHY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG TUMOR; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; THROMBOCYTE AGGREGATION; TUMOR LOCALIZATION;

AMINO ACID SEQUENCE; ANIMALS; CELL ADHESION; CELL MOVEMENT; CHROMATOGRAPHY; CROTALID VENOMS; CROTALUS; DISINTEGRINS; DOSE-RESPONSE RELATIONSHIP, DRUG; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDE MAPPING; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR CELLS, CULTURED;

ATRACTASPIDIDAE; COLUBRIDAE; CROTALUS ATROX; ELAPIDAE; MUS; SERPENTES; VIPERIDAE;

EID: 43649086736     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2008.02.004     Document Type: Article

References (42)

1. Adame B.L., Soto J.G., Secraw D.J., Perez J.C., Glenn J.L., and Straight R.C. Regional variation of biochemical characteristics and antigeneity in Great basin rattlesnake (Crotalus viridis lutosus) venom. Comp. Biochem. Physiol. 97B (1990) 95-101
2. Aguilar I., Guerrero B., Salazar A.M., Girón M.E., Pérez J.C., Sánchez E.E., and Rodríguez-Acosta A. Individual venom variability in the South American rattlesnake Crotalus durissus cumanensis. Toxicon 50 (2007) 214-224
3. Anonymous. Principles of Laboratory Animal Care (1985), National Institute of Health of United States, MD, USA Pub. 85-23, pp. 1-112
4. Arnaout M.A., Goodman S.L., and Xiong J.-P. Coming to grips with integrin binding to ligands. Curr. Opin. Cell Biol. 14 (2002) 641-651
5. Bartsch J.E., Edgar B.S., Staren D., and Appert H.E. Adhesion and migration of extracellular matrix-stimulated breast cancer. J. Surg. Res. 110 (2003) 287-294
6. Berlin C., Berg E.L., Briskin M.J., Andrew D.P., Kilshaw P.J., Holzmann B., Weissman I.L., Hamann A., and Butcher E.C. Alpha4 Beta7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74 (1994) 185-195
7. Beviglia L., Stewart G.J., and Niewiarowski S. Effect of four disintegrins on the adhesive and metastatic properties of B16F10 melanoma cells in a murine model. Oncol. Res. 7 (1995) 7-20
8. Brooks P.C., Montgomery A.M., Rosenfeld M., Reisfeld R.A., Hu T., Klier G., and Cheresh D.A. Integrin avb3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79 (1994) 1157-1164
9. Chin D., Boyle G.M., Kane A.J., Theile D.R., Hayward N.K., Pason P.G., and Coman W.B. Invasion and metastasis markers in cancer. Br. J. Plast. Med. 58 (2005) 466-474
10. Danen E.H., Marcinkiewicz C., Cornelissen I.M., Van K.A., Pachter J.A., Ruiter D.J., Niewiarowski S., and Van M.G. The disintegrin eristostatin interferes with integrins alpha 4 beta 1 function and with experimental metastasis of human melanoma cells. Exp. Cell Res. 238 (1998) 188-196
11. Diamond M.S., Staunton D.E., Marlin S.D., and Springer T.A. Binding of the integrin Mac-1 (Cd11b/Cd18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 65 (1991) 961-971
12. 2 subunit proximal to the collagen-binding site. Biochem. J. 376 (2003) 77-85
13. Galán J.A., Sánchez E.E., Bashir S., and Pérez J.C. Characterization and identification of disintegrins in Crotalus horridus venom by liquid chromatography and tandem matrix-assisted laser desorption ionization quadrupole ion trap time-of-flight (MALDI-QIT-TOF) mass spectrometry. Canadian J. Chem. 83 (2005) 1124-1131
14. Glenn J.L., and Straight R.C. Integration of two different venom populations of the Mojave rattlesnake (Crotalus scutulatus scutulatus) in Arizona. Toxicon 27 (1989) 411-418
15. Isoai A., Ueno Y., Giga-Hama Y., Goto H., and Kumagai H. A novel Arg-Gly-Asp containing peptide specific for platelet aggregation and its effect on tumor metastasis: a possible mechanism of RGD peptide-mediated inhibition of tumor metastasis. Cancer Lett. 65 (1992) 259-264
16. Jin H., and Varner J. Integrins: roles in cancer development and as treatment targets. Br. J. Cancer 90 (2004) 561-565
17. Kang I.-C., Kim D.-S., Jang Y., and Chung K.-H. Suppressive mechanism of salmosin, a novel disintegrin in B16 melanoma cell metastasis. Biochem. Biophys. Res. Commun. 275 (2000) 169-173
18. Kudlacz E., Whitney C., Andersen C., Duplantier A., Beckius G., Chupak L., Klein A., Kraus K., and Milici A. Pulmonary eosinophilia in a murine model of allergic inflammation is attenuated by small molecule alpha 4 beta 1 antagonists. J. Pharmacol. Exp. Ther. 301 (2002) 747-752
19. Kurschat P., and Mauch C. Mechanisms of metastasis. Clin. Exp. Dermatol. 25 (2000) 482-489
20. Lin E.C.K., Ratnikov B.I., Tsai P.M., Carron C.P., Myers D.M., Barbas C.F., and Smith J. Identification of a region in the integrin b3 subunit that confers ligand binding specificity. J. Biol. Chem. 272 (1997) 23912-23920
21. McLane M.A., Sanchez E.E., Wong A., Paquette-Straub C., and Perez J.C. Disintegrins. Curr. Drug Targets Cardiovasc. Haematol. Disorders 4 (2004) 327-355
22. 1 integrin is involved in melanoma cell migration and invasion. Exp. Cell Res. 219 (1995) 233-242
23. Mousa S., Mohamed S., Smallhear J., Jadhav P.K., and Varner J. Anti-angiogenesis efficacy of small molecule a5b1 integrin antagonist. Blood 94 Suppl 1 (1999) 620a, 2755
24. Mzejewski G.J. Role of integrins in cancer: survey of expression patterns. Proc. Soc. Exp. Biol. Med. 222 (1999) 124-138
25. Okegawa T., Pong E.C., Li Y., and Hsieh J.T. The role of cell adhesion molecule in cancer progression and its application in cancer therapy. Acta Biochim. Pol. 51 (2004) 445-457
26. Oshikawa K., and Terada S. Ussuristatin 2, a novel KGD-bearing disintegrin from Agkistrodon ussuriensis venom. J. Biochem. (Tokyo) 125 (1999) 31-35
27. Plow E.F., Haas T.A., Zhang L., Loftus J., and Smith J.W. Ligand binding to integrins. J. Biol. Chem. 275 (2000) 21785-21788
28. Raso E., Tovari J., Toth K., Paku S., Trikha M., Honn K.V., and Timar J. Ectopic alphaIIbbeta3 integrin signaling involves 12-lipoxygenase- and PKC-mediated serine phosphorylation events in melanoma cells. Thromb. Haemostasis 85 (2001) 1037-1042
29. Salazar A.M., Rodríguez-Acosta A., Girón M.E., Aguilar I., and Guerrero B. A comparative analysis of the clotting and fibrinolytic activities of the mapanare (Bothrops atrox) snake venom from different geographical areas in Venezuela. Thromb. Res. 120 (2007) 95-104
30. Sánchez E.E., Galán J.A., Powell R.L., Reyes S.R., Soto J.G., Russell W.K., Russell D.H., and Pérez J.C. Disintegrin, hemorrhagic, and proteolytic activities of Mohave rattlesnake, Crotalus scutulatus scutulatus, venoms lacking Mojave toxin. Comp. Biochem. Phys. Part C 141 (2005) 124-132
31. Sánchez E.E., Galán J.A., Russell W.K., Russell D.H., Soto J.G., and Pérez J.C. Isolation and characterization of two disintegrins from the venom of Crotalus scutulatus scutulatus (Mohave rattlesnake). Toxinol. Appl. Pharmacol. 212 (2006) 59-68
32. Scarborough R.M., Rose J.W., Naughton M.A., Phillips D.R., Nannizzi L., Arfsten A., Campbell A.M., and Charo I.F. Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. J. Biol. Chem. 268 (1993) 1058-1065
33. Soto J.G., Perez J.C., Lopez M.M., Martinez M., Quintanilla-Hernandez T.B., Santa-Hernandez M.S., Turner K., Glenn J.L., Straight R.C., and Minton S.A. Comparative enzymatic study of HPLC-fractionated Crotalus venoms. Comp. Biochem. Physiol. 93B (1989) 847-855
34. Soto J.G., Powell R.L., Reyes S.R., Wolana L., Swanson L.J., Sanchez E.E., and Perez J.C. Genetic variation of a disintegrin gene found in the American copperhead snake (Agkistrodon contortrix). Gene 373 (2006) 1-7
35. 1 integrin cell surface collagen receptor binds to the α1(I)-CB3 peptide of collagen. J. Biol. Chem. 265 (1990) 4778-4781
36. Staunton D.E., Dustin M.L., Erickerson H.P., and Springer T.A. The arrangement of the immunoglobin-like domains of ICAM-1 and the binding sites for LFA and rhinovirus. Cell 61 (1990) 243-254
37. Taga T., Suzuki L., Gonzalez-Gomez I., Gilles F.H., Stins M., Shimada H., Barsky L., Weinberg K.I., and Laug W.E. Alpha v-integrin anagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin. Int. J. Cancer 98 (2002) 690-697
38. Trikha M., Zhou Z., Timar J., Raso E., Kennel M., Emmell E., and Nakada M.T. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis. Cancer Res. 62 (2002) 2824-2833
39. Trochon-Joseph V., Martel-Renoir D., Mir L.M., Thomaidis A., Opolon P., Connault E., Li H., Grenet C., Fauvel-Lafeve F., Soria J., Legrand C., Soria C., Perricaudet M., and Lu H. Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin. Cancer Res. 64 (2004) 2062-2069
40. Tucker G.C. Inhibitors of integrins. Curr. Opin. Pharmacol. 2 (2002) 394-402
41. Velasco-Velazquez M.A., Molina-Guarneros J.A., Mendoza-Patino N., Sullivan J., and Mandoki J.J. Integrins and integrin-associated molecules: targets for the development of antimetastatic therapies. Rev. Invest. Clin. 51 (1999) 183-193
42. Wierzbicka-Patynowski I., Niewiarowski S., Marcinkiewicz C., Calvete J.J., Marcinkiewicz M.M., and McLane M.A. Structural requirements of echistatin for the recognition of αvβ3 and α5β1 integrins. J. Biol. Chem. 274 (1999) 37809-37814